Cookie policy

This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read our Privacy And Cookies Policy

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content




K-Pack® II Needles

Ready for your most challenging pharmaceutical applications K-Pack® II Needles for hypodermic injections are carefully crafted for smoother, less painful injections of today’s parenteral products.


Superior sharpness and smoothness every time

Developed to meet the needs of patients and drug developers, K-Pack® II Needles are precisely manufactured to reduce penetration resistance. In fact, Independent testing confirmed Terumo Pharmaceutical Solutions’ T-SharpTM triple-bevel lancet tips have superior performance compared to other significant brands.1

Designed for subcutaneous, intra-muscular and intravenous injections, K-Pack® II needles offer the compatibility, quality and supply reliability needed to meet parenteral delivery challenges and product commercialization goals. 

Patient's comfort in mind

  • T-Sharp™ lancet tip for low penetrations forces
  • Silicon coating for smoother, low drag forces during insertions
  • Thin, extra-thin, and ultra-thin-wall cannulas for managing viscosity relative to outside diameter to address advantages for extrusion force and flow rates2

Engineered for automated environments

  • Individually packed in ergonomically formed hard-plastic case for automated needle handling and assembly
  • Color-coded tamper-evident label with 2D barcode for 3600 in-line vision inspection
  • Sterilized and ready for controlled environment manufacturing
  • Rounded container design for faster automated pick-and-place assembly routines 

Regulatory and Quality Aspects

  • Ethylene oxide sterilization Sterility Assurance Level at least 10-6
  • In compliance with applicable ISO standards and European Pharmacopoeia 
  • CE-marked and FDA-cleared
  • Proven track record of reliable supply assured by global operating company

General specifications

K-Pack® II Needles are intended for subcutaneous, intra-muscular and intravenous applications.

Specification Description
Needle PointT-SharpTM Triple-bevel lancet point
CannulasStainless steel X5CrNi 18-10
Individual packagingRigid polypropylene
Shipping carton
(standard, other packaging configurations possible)
5000 pcs.
SterilizationEthylene Oxide
Shelf-life5 years

Global Solutions

K-Pack® II Needle solutions are available to drug product manufacturers globally. For more information about product availability, specifications, and applicable standards, download our data sheet or contact your Terumo representative today.

Please note that some products may not be available in all regions, check with your local TERUMO Pharmaceuticals Solutions contact for details.


Relevant product information
K-Pack II Datasheet 2022


1 Comparative Hypodermic Needle Sharpness Among Major Brands, 2009 

2Data on file​

Let’s Find Your Best Solution

Innovation and creativity are central to Terumo Pharmaceutical Solutions’ value proposition. Our expert teams lead the industry in developing and manufacturing advanced, high-performing infusion and injection technologies for all parenteral applications.

Contact Us

Didn't find your product?

Consult our products in our Product Index

Are you a pharmaceutical professional?

This information is intended for professionals in the pharmaceutical supply chain who are interested in primary packaging, injection components and medical devices from Terumo Pharmaceutical Solutions, for use in combination with their respective drug products (hereafter, pharmaceutical professionals). Please note that the product information contained on this website is exclusively addressed to pharmaceutical professionals. This product information is not for the general public, nor is it intended to be a substitute for professional medical advice or for the care that patients receive from their healthcare professionals. By accessing it, you (i) acknowledge having read and understood both the above message and our terms of use and, further, (ii) confirm that you do so in the capacity of a pharmaceutical professional.